Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever

Pediatric Rheumatology

Volumn 8, Issue , 2010, Pages

  Pelajo, Christina F ^a   Lopez Benitez, Jorge M ^a   Torres, Juliana M ^b   de Oliveira, Sheila K F ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAZIL; CHILD; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RHEUMATIC FEVER; SCHOOL CHILD;

EID: 77954871699     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/1546-0096-8-22     Document Type: Article

References (34)

1. II Consenso sobre Prevenção da Febre Reumática da Sociedade Brasileira de Pediatria. Correios da SBP 2004, 10:9-14.
2. Rayamajhi A, Sharma D, Shakya U. First-episode versus recurrent acute rheumatic fever: is it different?. Pediatr Int 2009, 51:269-75. 10.1111/j.1442-200X.2008.02743.x, 19405931.
3. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005, 366:155-68. 10.1016/S0140-6736(05)66874-2, 16005340.
4. Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, Taubert KA. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009, 119:1541-51. 10.1161/CIRCULATIONAHA.109.191959, 19246689.
5. Nordet P, Lopez R, Duenas A, Sarmiento L. Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986-1996-2002). Cardiovasc J Afr 2008, 19:135-40.
6. Steer AC, Carapetis JR. Acute rheumatic fever and rheumatic heart disease in indigenous populations. Pediatr Clin North Am 2009, 56:1401-19. 10.1016/j.pcl.2009.09.011, 19962028.
7. Carapetis JR, Currie BJ. Preventing rheumatic heart disease in Australia. Med J Aust 1998, 168:428-9.
8. Carapetis JR, Mayosi BM, Kaplan EL. Controlling rheumatic heart disease in developing countries. Cardiovasc J S Afr 2006, 17:164-5.
9. Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med 2007, 357:439-41. 10.1056/NEJMp078039, 17671252.
10. Carapetis JR, Kilburn CJ, MacDonald KT, Walker AR, Currie BJ. Ten-year follow up of a cohort with rheumatic heart disease (RHD). Aust N Z J Med 1997, 27:691-7.
11. Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev 3 2002, CD002227.
12. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992, 268:2069-73. 10.1001/jama.268.15.2069, 1404745, Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update.
13. Saxena A. Diagnosis of rheumatic fever: current status of Jones Criteria and role of echocardiography. Indian J Pediatr 2000, 67:S11-4.
14. Stewart T, McDonald R, Currie B. Acute rheumatic fever: adherence to secondary prophylaxis and follow up of Indigenous patients in the Katherine region of the Northern Territory. Aust J Rural Health 2007, 15:234-40. 10.1111/j.1440-1584.2007.00896.x, 17617086.
15. McDonald M, Brown A, Noonan S, Carapetis JR. Preventing recurrent rheumatic fever: the role of register based programmes. Heart 2005, 91:1131-3. 10.1136/hrt.2004.057570, 1769085, 16103536.
16. Kumar R. Controlling rheumatic heart disease in developing countries. World Health Forum 1995, 16:47-51.
17. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002, 288:2880-3. 10.1001/jama.288.22.2880, 12472330.
18. Herdy GV. [The challenge of secondary prophylaxis in rheumatic fever]. Arq Bras Cardiol 1996, 67:317.
19. Kumar R, Thakur JS, Aggarwal A, Ganguly NK. Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of northern India. Indian Heart J 1997, 49:282-8.
20. Robertson KA, Volmink JA, Mayosi BM. Lack of adherence to the national guidelines on the prevention of rheumatic fever. S Afr Med J 2005, 95:52-6.
21. Ferrieri P. Proceedings of the Jones Criteria workshop. Circulation 2002, 106:2521-3. 10.1161/01.CIR.0000037745.65929.FA, 12417554.
22. Meira ZM, Goulart EM, Colosimo EA, Mota CC. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart 2005, 91:1019-22. 10.1136/hrt.2004.042762, 1769032, 16020588.
23. WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from Phase I (1986-90) WHO Cardiovascular Diseases Unit and principal investigators. Bull World Health Organ 1992, 70:213-8. 2393294, 1600581.
24. Berrios X, del Campo E, Guzman B, Bisno AL. Discontinuing rheumatic fever prophylaxis in selected adolescents and young adults. A prospective study. Ann Intern Med 1993, 118:401-6.
25. Bassili A, Zaher SR, Zaki A, Abdel-Fattah M, Tognoni G. Profile of secondary prophylaxis among children with rheumatic heart disease in Alexandria, Egypt. East Mediterr Health J 2000, 6:437-46.
26. Ralph A, Jacups S, McGough K, McDonald M, Currie BJ. The challenge of acute rheumatic fever diagnosis in a high-incidence population: a prospective study and proposed guidelines for diagnosis in Australia's Northern Territory. Heart Lung Circ 2006, 15:113-8. 10.1016/j.hlc.2005.08.006, 16574535.
27. Harrington Z, Thomas DP, Currie BJ, Bulkanhawuy J. Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust 2006, 184:514-7.
28. Macedo A, Primo M, Kaku S, Lima M, Sampayo EF. [Rheumatic cardiopathy in children. A comparative study in 2 consecutive 9-year periods]. Acta Med Port 1989, 2:127-31.
29. Eissa S, Lee R, Binns P, Garstone G, McDonald M. Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community. Aust N Z J Public Health 2005, 29:521-5. 10.1111/j.1467-842X.2005.tb00243.x, 16366062.
30. Naim M, Tjipta GD, Siregar AA, Halim S. Rheumatic fever and rheumatic heart disease at the Department of Child Health, School of Medicine, University of North Sumatera/Dr. Pirngadi Hospital, Medan (1983-1985). Paediatr Indones 1989, 29:64-71.
31. Mincham CMMD, Plant AJ. The quality of management of rheumatic fever/heart disease in the Kimberley. Aust N Z J Public Health 2002, 26:417-20. 10.1111/j.1467-842X.2002.tb00340.x, 12413284.
32. Gubert ICKL, Vizzotto AO, Leão MTC. Critical evaluation of diagnostic and secondary prophylaxis in 259 cases of rheumatic fever. Rev Med Paraná 1997, 54:48-54.
33. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002, 288:2868-79. 10.1001/jama.288.22.2868, 12472329.
34. Herdy GV, Souza DC, Barros PB, Pinto CA. [Secondary prophylaxis in rheumatic fever. Oral antibiotic therapy versus benzathine penicillin]. Arq Bras Cardiol 1996, 67:331-3.